Rankings
▼
Calendar
ARGX Q4 2018 Earnings — argenx SE Revenue & Financial Results | Market Cap Arena
ARGX
argenx SE
$45B
Q4 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$9M
-46.8% YoY
Gross Profit
-$41M
-463.8% margin
Operating Income
-$56M
-646.5% margin
Net Income
-$47M
-533.2% margin
EPS (Diluted)
$-1.35
Cash Flow
Operating Cash Flow
-$26M
Free Cash Flow
-$27M
Stock-Based Comp.
$15M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$9M
$16M
-46.8%
Gross Profit
-$41M
-$9M
-361.5%
Operating Income
-$56M
-$19M
-190.9%
Net Income
-$47M
-$20M
-134.2%
← Q2 2018
All Quarters
Q2 2019 →